ArticleCancer drug resistance (Alhambra, Calif.)2022

GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies.

Khoa Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.